scispace - formally typeset
Search or ask a question

Showing papers by "Loralie J. Langman published in 2014"

Journal Article•DOI•
Hydrocodone in postoperative personalized pain management: pro-drug or drug?

[...]

M. Elaine Stauble1, Andrew W. Moore1, Loralie J. Langman2, Mark V. Boswell1, Richard N. Baumgartner1, Suzanne McGee1, Jonathan Metry1, Saeed A. Jortani1 •
University of Louisville1, Mayo Clinic2
15 Feb 2014-Clinica Chimica Acta
TL;DR: This study shows that hydromorphone is generated at substantially different rates, dependent on CYP2D6 genotype, and suggests that pain relief will vary with CYP1D5 genotype.

49 citations

Journal Article•DOI•
The development and validation of a turbulent flow-liquid chromatography–tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum

[...]

Athena K. Petrides1, Joshua Moskowitz1, Kamisha L. Johnson-Davis2, Paul J. Jannetto3, Loralie J. Langman3, William Clarke1, Mark A. Marzinke1 •
Johns Hopkins University School of Medicine1, University of Utah2, Mayo Clinic3
01 Oct 2014-Clinical Biochemistry
TL;DR: A turbulent flow-liquid chromatography-tandem mass spectrometric (TFC-MS/MS) method for the robust, simultaneous quantification of citalopram, sertraline, bupropion and its active metabolite, hydroxyb upropion (OH-bupropion).

12 citations